Stockscreener 앱 받기
1.95
1.56%
0.03
시간 외 거래:
1.98
0.03
+1.54%
Century Therapeutics Inc 주식(IPSC)의 최신 뉴스
HC Wainwright Issues Pessimistic Forecast for IPSC Earnings - MarketBeat
TD Cowen Maintains Century Therapeutics(IPSC.US) With Buy Rating - Moomoo
Century Therapeutics, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Century Therapeutics Releases Q2 2026 Financial Results - AlphaStreet
Century Therapeutics (NASDAQ:IPSC) Issues Quarterly Earnings Results - MarketBeat
Century Therapeutics Announces Q2 2026 Financial Results and Updates Investor Presentation in 8-K Filing - Kalkine Media
Form 8K Century Therapeutics Inc For: 12 August - Investing.com India
Century Therapeutics Reports Q2 Results, Pipeline Advancements - TipRanks
Form 8K Century Therapeutics Inc For: 12 August By Investing.com - Investing.com Canada
Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates - The Manila Times
Century Therapeutics posts $34.6 million Q2 loss as cash runway reaches 2029 - Quiver Quantitative
Century Therapeutics 2Q 2026: Revenue $0 EPS $(0.17) — 10-Q Summary - TradingView
Century Therapeutics Q2 net loss misses estimates on lease termination loss - TradingView
Century Therapeutics (IPSC) books $34.6M loss but holds $197M cash - Stock Titan
FDA and Century Align on Type 1 Diabetes Therapy Trial Plan - Stock Titan
We Think Century Therapeutics (NASDAQ:IPSC) Needs To Drive Business Growth Carefully - Moomoo
Century Therapeutics (IPSC) Projected to Announce Earnings on Thursday - MarketBeat
Century Therapeutics (IPSC) SVP has automatic share sale to cover RSU taxes - Stock Titan
Seven Fleet Capital Management LP Takes Position in Century Therapeutics, Inc. $IPSC - MarketBeat
DV Trading LLC Makes New Investment in Century Therapeutics, Inc. $IPSC - MarketBeat
Century Therapeutics Inc expected to post a loss of 11 cents a shareEarnings Preview - TradingView
Century Therapeutics Inc (IPSC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Century Therapeutics Inc (IPSC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Commodore Capital LP Purchases New Position in Century Therapeutics, Inc. $IPSC - MarketBeat
Century Therapeutics Inc (IPSC) Cash Flow - TradingKey
IPSC|Century Therapeutics Inc|Price:2.110|Chg%:-0.060 - TradingKey
Century Therapeutics Inc (IPSC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Century Therapeutics Inc (IPSC) Institutional Confidence - TradingKey
Century Therapeutics, Inc. Revenue Breakdown – NASDAQ:IPSC - TradingView
Spruce Street Capital LP Acquires 2,637,522 Shares of Century Therapeutics, Inc. $IPSC - MarketBeat
Century Therapeutics Inc (IPSC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IPSC stock trades steadily as Century Therapeutics updates its pipeline and cash runway - Ad-hoc-news.de
IPSC stock trades around recent lows as Century Therapeutics weighs pipeline and cash burn - Ad-hoc-news.de
Century Therapeutics (IPSC) Dips 2.7% as Shares Near Key Support ZoneDividend Stock Picks - dars.gov.et
Century Therapeutics (IPSC) to Present CNTY-813 Data at Scientific Congresses - Yahoo Finance
Century: 'Hold' Based On CNTY-101 Pivot And CNTY-813 T1D Curative Potential - Seeking Alpha
Century Therapeutics abstracts accepted for diabetes conferences - Investing.com
Century Therapeutics abstracts accepted for diabetes conferences By Investing.com - Investing.com South Africa
Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026 - Investing News Network
Century Therapeutics (IPSC) Q1 2026 Earnings: Narrower Loss Surprises, Shares ClimbEarnings Growth Analysis - dars.gov.et
Frontier tech research, news & data - MLQ.ai
IPSC Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Stock ReactionEstimate Dispersion - dars.gov.et
IPSCCentury Therapeutics Inc Short Interest - Finviz
Price to sales forward of Century Therapeutics, Inc. – NASDAQ:IPSC - TradingView
IPSC News | CENTURY THERAPEUTICS INC (NASDAQ:IPSC) - ChartMill
Century Therapeutics, Inc.(NasdaqCM: IPSC) added to Russell 2000 Index - marketscreener.com
Century Therapeutics, Inc.(NasdaqCM: IPSC) added to Russell 2000 Value Benchmark - marketscreener.com
Century Therapeutics, Inc.(NasdaqCM:IPSC) added to Russell Microcap Value Benchmark Index - marketscreener.com
Century Therapeutics, Inc.(NasdaqCM: IPSC) added to Russell Microcap Index - marketscreener.com
Century Therapeutics (IPSC) Holds Support With Modest Gain Amid Biotech Sector UncertaintyBreakaway Gap - dars.gov.et
Century Therapeutics, Inc. Actuals & Estimates (NASDAQ:IPSC) - TradingView
Enterprise value to EBIT forward of Century Therapeutics, Inc. – NASDAQ:IPSC - TradingView
Price to earnings forward of Century Therapeutics, Inc. – NASDAQ:IPSC - TradingView
IPSC Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Century Therapeutics, Inc. – NASDAQ:IPSC - TradingView
Century Therapeutics updates its CAR-T pipeline, shares trade on Nasdaq - Ad-hoc-news.de
Century Therapeutics Inc (IPSC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight - GlobeNewswire Inc.
Century Therapeutics Inc. (IPSC) Edges Higher as Biotech Stock Tests Key Resistance ZoneTick Index - po-news-eg.net
Century Therapeutics Inc (IPSC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Century Therapeutics Inc (IPSC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
1.80%
1.77%
자본화:
|
볼륨(24시간):